The fungus Phaeosphaeria spartinae is an endophyte of the marine alga Ceramium sp. Investigation of this marine-derived fungus led to the isolation of spartinoxide (1), which is the enantiomer of the known compound A82775C (2). Additionally, the known metabolites 4-hydroxy-3-prenyl-benzoic acid (4) and anofinic acid (5) were obtained. The structures of all compounds were established from extensive spectroscopic investigations. Compounds 1, 4 and 5 were assayed against the enzymes human leukocyte elastase (HLE), trypsin, acetylcholinesterase and cholesterolesterase. Compounds 1 and 4 showed potent inhibition of HLE with IC 50 values of 1.71 ± 0.30 μg/mL (6.5 μM) and 1.67 ± 0.32 μg/mL (8.1 μM), respectively.
The marine environment is distinguished by unique groups of organisms being the source of a wide array of fascinating structures [1] . Microorganisms are an increasingly productive and successful focus for marine natural products research [2] . In the search for novel secondary metabolites from microbes, we have focused on fungi associated with marine algae. Associations between micro-and macro-organisms are a prominent feature of marine ecosystems [3, 4] . Biological and chemical screening of fungal strains isolated from the inner tissue of algae directed our attention to the fungus Phaeosphaeria spartinae. This paper reports on the isolation and structure elucidation of the new polyketide spartinoxide (1) , which is the enantiomer of the known compound A82775C (2) . Compound 1 showed potent inhibitory activity toward human leukocyte elastase (HLE). Also, we report in this paper the known compounds 4-hydroxy-3-prenyl-benzoic acid (4) and anofinic acid (5) , of which 4 is also a strong inhibitor of HLE.
HLE belongs to the chymotrypsin family of serine proteinases and is responsible for the cleavage of elastin, an elastic protein in connective tissues. The enzyme is located in the azurophilic granules of polymorphonuclear leukocytes and is involved in the migration of neutrophiles from blood to various tissues, such as airways, in response to chemotactic factors [5, 6] . Excessive activity of this enzyme can result in diseases such as pulmonary emphysema, rheumatoid arthritis, and cystic fibrosis [7, 8] . Thus, HLE inhibitors are of considerable therapeutic interest. To date, recombinant endogenous elastase inhibitors are already available, for example, secretory leukocyte proteinase inhibitor or α-1-proteinase inhibitor. Sivelestat, a sulfonamide, is the only synthetic inhibitor that has reached the clinical market [9, 10] . Structure of compound 1 isolated from Phaeosphaeria spartinae, and known isomers thereof [11] [12] [13] [14] . b data from literature [11] . c data from literature [12] [13] [14] IR spectrum showed a broad OH stretching vibration at 3335 cm -1 , which is correspondent to free, non-chelated hydroxyl groups. Our attention was first attracted to compound 1 by the resonance at δ c 204.7 in the 13 C NMR spectrum, without any evidence for a carbonyl functionality in the IR spectrum, suggesting the presence of an allene functionality. This allenic C-11 is strongly downfield shifted owing to the strong anisotropic diamagnetic effect exerted by both double bonds, i.e. Δ 10,11 and Δ 11,12 .
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In the 1 H- forms an isoprenyl unit, which is attached to the cyclohexane ring at C-6 due to cross peak correlations between H 2 -5 and C-6, and C-7 and C-16 in the 1 H-13 C HMBC spectrum. In the same spectrum the resonance signal for H-16 correlates with that of C-9, C-10 and C-11. CH-7, CH-8, and CH 2 -9 are connected to each other, as drawn in Figure 1 due to mutual correlations in the 1 H-1 H COSY spectrum (Table 1 , Figure 2 and Figures S4 and S5) . In the 1 H-13 C HMBC, H 3 -15 correlates with C-13 indicating its direct attachment to C-13, which is substantiated by the singlet and more down-field resonance in the 1 H NMR spectrum (δ H 1.82 for H 3 -15) . The resonance at δ c 113.8 in the 13 C NMR spectrum results from the terminal methylene group CH 2 -14, as evident from the DEPT 135 and HSQC spectra ( Figures S2 and S3 in supplementary data) . CH 2 -14, together with CH 3 -15, is connected to C-13, as deduced from 1 H- 13 C HMBC cross peak correlations. This methyl substituted vinylic unit is attached to C-12 due to cross peak correlations of H-12 with C-14 and C-15 in the 1 H-13 C HMBC spectrum. Additionally, H-14a correlates with C-15 and the other methylene proton H14b with C-12, C-13 and C-15, thus attaching the allene to the terminal vinyl moiety, as shown in Figure 2 .
The molecular formula of compound 1 was deduced by accurate mass measurement to be 285.1461 (M+Na) + , which requires six degrees of unsaturation. Five of these have been accounted for by four double bonds (Δ 3, 4 , Δ 10, 11 , Δ 11,12 , and Δ 13,14 ) and the cyclohexane ring. Compound 1 must be bicyclic, and the second cyclization occurs between carbons C-6 and C-7. In the 1 H and 13 C NMR spectra, C-6, CH-7, CH-8 and CH-16 showed resonance signals indicative for substitution with oxygen. Owing to the 13 C NMR chemical shifts of C-6 (δ 65.3) and C-7 (δ 63.9), the second ring is an epoxide, as encountered in 2 and 3. The planar structure of 1 is supported by comparing the published spectroscopic data of 2 [11] and 3 [12] [13] [14] with those of 1.
Even though compounds 2 and 3 are stereoisomers, their NMR data are very similar. Thus, in order to determine the stereostructure of 1, a detailed analysis had to be undertaken.
Stereochemistry of compound 1:
The stereochemistry of compound 1, including the allene and chiral centres at C-6, C-7, C-8 and C-16, was determined from NOESY data, 1 H-1 H J values and by comparing its specific optical rotation with that of compound 2. The singlet resonance of H-7 in the 1 H NMR spectrum indicates that the dihedral angle between H-7 and H-8 is θ 7-8 ≈ 90 o according to the Karplus equation [15] , which requires that the orientation of OH-8 is opposite to that of the epoxy group. H-8 showed cross peak correlations in the NOESY spectrum with both H-9a and H-9b, indicating that the orientation of H-8 is in between H-9a and H-9b (J 8-9a = 7.7 Hz; J 8-9b = 5.5 Hz). The correlation in the 1 H-1 H COSY between H-7 and H-9b is due to W-coupling and therefore these protons are on the same side of the molecule, i.e. β-oriented. The NOESY correlation between H-9a and H-16 places these two protons on the other side of the molecule, i.e. α-oriented. The allenic proton H-12 showed a cross peak correlation in the NOESY spectrum with H-9b. From all NOESY correlations observed a sofa conformation for the whole molecule is proposed (Table 1, Figure 3 and Figure S6 in supplementary data). The relative configuration of compound 1 is thus identical to that of 2. Compound 1, however is the enantiomer of compound 2 due to the opposite specific optical rotation ([α] 23 D -180 for compound 1 and +175 for compound 2 [11] ). Therefore, the absolute configuration of compound 1 is determined to be 6S, 7R, 8S, 11S, 16R. We propose the generic name spartinoxide for compound 1. data ( Figures S9, S10 , S12 and S13 in supplementary data). All data agreed well with those reported. Compounds 4 [15] [16] [17] [18] [19] [20] [21] [22] and 5 [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] were described before from several source organisms and shown to possess many biological activities. There is no reported biological activity for 2 and 3; only the extract from which compound 3 derived showed inhibition of HIV-1 replication in C8166 cells [12] [13] [14] .
Experimental
General experimental procedures: UV and IR spectra were obtained employing Perkin-Elmer Lambda 40 and Perkin-Elmer Spectrum BX instruments, respectively. VLC grade Si gel (40-63 µm) was used for vacuum liquid chromatography. All organic solvents were distilled prior to use. HPLC was carried out using a Waters system, controlled by Waters Millenium software, consisting of a 600 pump, a 996 PDA, and a 717 plus autosampler.
1 H and 13 C NMR spectra were recorded on a Bruker Avance 300 DPX spectrometer in CD 3 OD. NMR spectra were referenced to residual solvent signals of CD 3 OD at δ H/C 3.35 / 49.0. Optical rotations were measured with a Jasco DIP 140 polarimeter. ESI mass spectra were obtained on an Applied Biosystems/MDS Sciex API 2000 MS. The enzymatic assay was performed on a Varian Cary 100 Bio spectrophotometer. Human leukocyte elastase (HLE) was obtained from Calbiochem, Darmstadt, Germany. The chromogenic substrate MeOSuc-AlaAla-Pro-Val-NHNp (Np: 4-nitrophenyl) was obtained from Bachem, Bubendorf, Switzerland.
Origin of the algal sample, isolation and taxonomy of the fungus: An algal sample belonging to the genus Ceramium was collected from the North Sea, Büsum, Germany. The isolation of the fungus was carried out using an indirect isolation method. Algal samples were rinsed 3 times with sterile H 2 O. After surface sterilization with 70% EtOH for 15 s the alga was rinsed in sterile artificial seawater (ASW) [34] . Subsequently, the alga was aseptically cut into small pieces and placed on agar plates containing isolation medium: agar 15 g/L, ASW 800 mL/L, glucose 1 g/L, peptone from soymeal 0.5 g/L, yeast extract 0.1 g/L, benzyl penicillin 250 mg/L, and streptomycin sulfate 250 mg/L. The fungus growing out of the algal tissue was separated on biomalt medium (biomalt 20 g/L, agar 10 g/L, ASW 800 mL/L) until the culture was pure.
The fungal strain number 717 was identified as Phaeosphaeria spartinae by Dr C. Decock, BCCM/MUCL, Belgium.
Cultivation:
The fungal strain P. spartinae was cultivated for 40 days on 10 L solid Czapek-Dox medium (Becton Dickinson, France) with agar (15 g/L) at room temperature in 40 Fernbach flasks.
Extraction and isolation:
Fungal biomass and media were homogenized using an Ultra-Turrax apparatus and extracted with 8 L EtOAc to yield 10 g of crude extract. This material was fractionated by Si VLC using a stepwise gradient solvent system of increasing polarity starting from 20% acetone in light petroleum to 100% acetone, which yielded 28 fractions. RP-HPLC separation of subfraction 15 (column: Phenomenex C 18 Luna-100, 250 x 10 mm, 5µm; MeOH/H 2 O (48:52), 2 mL/min) afforded compound 1 (10 mg). RP-HPLC separation of subfraction 18 (same column; ACN/H 2 O (35:65), 2 mL/min) afforded compounds 4 (10 mg) and 5 (5 mg).
Biological activity -HLE inhibition assay: HLE was assayed spectrophotometrically at 405 nm at 25°C [35] . Assay buffer was 50 mM sodium phosphate buffer (500 mM NaCl, pH 7.8). A stock solution of the chromogenic substrate MeOSuc-Ala-Ala-Pro-ValNHNp was prepared in DMSO and diluted with assay buffer. Inhibitor stock solutions (10 mg/mL) were prepared in DMSO. Final concentration of DMSO was 1.5% (6.7% in the case of 5), the final concentration of MeOSuc-Ala-Ala-Pro-Val-NHNp was 100 μM. Assays were performed with a final HLE concentration of 50 ng/mL. An inhibitor solution (10 μL) and the substrate solution (50 μL) were added to a cuvette that contained the assay buffer (890 μL), and the solution was thoroughly mixed. The reaction was initiated by adding the HLE solution (50 μL) and was followed over 10 min. IC 50 values were calculated from the linear steadystate turnover of the substrate. HLE inhibition was
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Compound 1
Yellowish white powder (10 mg, 1 mg/L).
[α] 
Supplementary data:
1 H-, 13 C-and 2D-NMR spectra, and MS data of compounds 1, 4 and 5. Dose-dependent inhibition of HLE by compounds 1 and 4.
